73 related articles for article (PubMed ID: 10961938)
1. Protective peptides derived from novel glial proteins.
Brenneman DE; Spong CY; Gozes I
Biochem Soc Trans; 2000; 28(4):452-5. PubMed ID: 10961938
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.
Kumral A; Yesilirmak DC; Sonmez U; Baskin H; Tugyan K; Yilmaz O; Genc S; Gokmen N; Genc K; Duman N; Ozkan H
Brain Res; 2006 Oct; 1115(1):169-78. PubMed ID: 16938277
[TBL] [Abstract][Full Text] [Related]
3. Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.
Brenneman DE; Hauser J; Neale E; Rubinraut S; Fridkin M; Davidson A; Gozes I
J Pharmacol Exp Ther; 1998 May; 285(2):619-27. PubMed ID: 9580606
[TBL] [Abstract][Full Text] [Related]
4. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress.
Steingart RA; Solomon B; Brenneman DE; Fridkin M; Gozes I
J Mol Neurosci; 2000 Dec; 15(3):137-45. PubMed ID: 11303778
[TBL] [Abstract][Full Text] [Related]
5. A femtomolar-acting neuroprotective peptide.
Brenneman DE; Gozes I
J Clin Invest; 1996 May; 97(10):2299-307. PubMed ID: 8636410
[TBL] [Abstract][Full Text] [Related]
6. The peptides ADNF-9 and NAP increase survival and neurite outgrowth of rat retinal ganglion cells in vitro.
Lagrèze WA; Pielen A; Steingart R; Schlunck G; Hofmann HD; Gozes I; Kirsch M
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):933-8. PubMed ID: 15728550
[TBL] [Abstract][Full Text] [Related]
7. VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide.
Brenneman DE; Glazner G; Hill JM; Hauser J; Davidson A; Gozes I
Ann N Y Acad Sci; 1998 Dec; 865():207-12. PubMed ID: 9928014
[TBL] [Abstract][Full Text] [Related]
8. The effects of vasoactive intestinal peptide in neurodegenerative disorders.
Deng G; Jin L
Neurol Res; 2017 Jan; 39(1):65-72. PubMed ID: 27786097
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.
Gressens P; Marret S; Hill JM; Brenneman DE; Gozes I; Fridkin M; Evrard P
J Clin Invest; 1997 Jul; 100(2):390-7. PubMed ID: 9218516
[TBL] [Abstract][Full Text] [Related]
10. A novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons.
Hirata K; Yamaguchi H; Takamura Y; Takagi A; Fukushima T; Iwakami N; Saitoh A; Nakagawa M; Yamada T
J Pharmacol Exp Ther; 2005 Jul; 314(1):252-9. PubMed ID: 15798005
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels.
Delgado M; Varela N; Gonzalez-Rey E
Glia; 2008 Aug; 56(10):1091-103. PubMed ID: 18442091
[TBL] [Abstract][Full Text] [Related]
12. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death.
Cao W; Tombran-Tink J; Chen W; Mrazek D; Elias R; McGinnis JF
J Neurosci Res; 1999 Sep; 57(6):789-800. PubMed ID: 10467250
[TBL] [Abstract][Full Text] [Related]
14. Mast cells reduce survival of myenteric neurons in culture.
Sand E; Themner-Persson A; Ekblad E
Neuropharmacology; 2009 Feb; 56(2):522-30. PubMed ID: 19013185
[TBL] [Abstract][Full Text] [Related]
15. The effects of 17beta-estradiol and ethanol on zinc- or manganese-induced toxicity in SK-N-SH cells.
Keller J; Owens CT; Lai JC; Devaud LL
Neurochem Int; 2005 Mar; 46(4):293-303. PubMed ID: 15707694
[TBL] [Abstract][Full Text] [Related]
16. Activity-dependent neuroprotective protein: from gene to drug candidate.
Gozes I
Pharmacol Ther; 2007 May; 114(2):146-54. PubMed ID: 17363064
[TBL] [Abstract][Full Text] [Related]
17. The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol.
Pascual M; Guerri C
J Neurochem; 2007 Oct; 103(2):557-68. PubMed ID: 17623041
[TBL] [Abstract][Full Text] [Related]
18. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.
Bassan M; Zamostiano R; Davidson A; Pinhasov A; Giladi E; Perl O; Bassan H; Blat C; Gibney G; Glazner G; Brenneman DE; Gozes I
J Neurochem; 1999 Mar; 72(3):1283-93. PubMed ID: 10037502
[TBL] [Abstract][Full Text] [Related]
19. A new concept in the pharmacology of neuroprotection.
Gozes I; Brenneman DE
J Mol Neurosci; 2000; 14(1-2):61-8. PubMed ID: 10854037
[TBL] [Abstract][Full Text] [Related]
20. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
Silva-Adaya D; Pérez-De La Cruz V; Herrera-Mundo MN; Mendoza-Macedo K; Villeda-Hernández J; Binienda Z; Ali SF; Santamaría A
J Neurochem; 2008 May; 105(3):677-89. PubMed ID: 18194214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]